Table 2.
Reviewed current case reports on NICTH with acromegaloid changes.
| Year | Age | Sex | Tumor location | Histopathology | Tumor size | IGF-2:IGF-1 | Intervention |
|---|---|---|---|---|---|---|---|
| 2019 (11) | 60 | Male | Liver | Solitary fibrous tumors | 6 × 13 × 11 cm | 8.54 | Portal embolization + sugery + prednisone |
| 2019 (12) | 69 | Femal | Pleural | Solitary fibrous tumors | 17.5 cm | 20.4 | Sugery + prednisone + glucagon |
| 2019 (12) | 70 | Femal | Pleural | Solitary fibrous tumors | 21 cm | 31.8 | Sugery + prednisone |
| 2013 (13) | 77 | Male | Retroperitoneal mas | Fibroma | 16 × 16 cm | 23.6 | Sugery + chemotherapy + RT + prednisolone |
| 2013 (13) | 32 | Femal | Right suprarenal | Adrenocortical carcinoma | 15.3 × 12.7 × 12 cm | 8.6 | Sugery |
| 2011 (14) | 53 | Femal | Right adrenal gland | Phaeochromocytoma | 15 × 14 × 20 cm | 31.5 | Octreotide + diazoxide |
| 2006 (15) | 53 | Male | Liver | Solitary fibrous tumors | NA | NA | Sugery |
| 2000 (16) | 63 | Femal | Left lung | Pleural fibrosarcoma | 18 × 10 cm | 11.2 | Sugery |
| 1995 (17) | 60 | Male | Pelvic tumor | Clear cell sarcoma | NA | 3.3 | Sugery |
NA, not available; RT, radiation therapy.